Showing results (21-30 of 588) with videos related to
Sort By:
Pageof 59
Expert Review of Anticancer Therapy|December 26, 2006
Update on therapy for melanoma: opportunities for patient selection and overcoming tumor resistanceHenry B Koon, Michael B AtkinsHematology/Oncology Clinics of North America|July 19, 2011
Future directions in renal cell carcinoma: 2011 and beyondDaniel C Cho, Michael B AtkinsClinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2014
Molecular pathways: can activin-like kinase pathway inhibition enhance the limited efficacy of VEGF inhibitors?Rupal S Bhatt, Michael B AtkinsJournal of Cancer Metastasis and Treatment|March 17, 2022
Current and emerging therapies for first line treatment of metastatic clear cell renal cell carcinomaMichael T Serzan, Michael B AtkinsCancer Treatment Reviews|September 3, 2018
Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinomaMichael B Atkins, Nizar M TannirAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
New agents and new targets for renal cell carcinomaGeorge K Philips, Michael B AtkinsCancer Medicine|January 10, 2014
PD-1 as a potential target in cancer therapyDavid F McDermott, Michael B AtkinsJournal for Immunotherapy of Cancer|August 27, 2025
How can we increase the value of clinical trials with immunotherapy?Michael B Atkins, David F McdermottExpert Opinion on Emerging Drugs|August 20, 2016
Emerging monoclonal antibodies for the treatment of renal cell carcinoma (RCC)Michael B Atkins, George K PhilipsCurrent Urology Reports|December 22, 2004
Chemotherapies and immunotherapies for metastatic kidney cancerYoo-Joung Ko, Michael B AtkinsPageof 59